Eli Lilly announces 650,000 additional doses of bamlanivimab purchased by US government to treat Covid-19

Eli Lilly announces 650,000 additional doses of bamlanivimab purchased by US government to treat Covid-19

Source: 
Pharmaceutical Business Review
snippet: 


The US government has purchased 650,000 additional doses of Eli Lilly and Company's (NYSE: LLY) neutralizing antibody bamlanivimab (LY-CoV555) 700 mg. The purchase agreement is for $812.5 million and the doses will be delivered through January 31, 2021, with at least 350,000 of the additional doses delivered in December 2020.